Glucose ingestion fails to inhibit hypothalamic neuronal activity in patients with type 2 diabetes

Diabetes

Volumn 56, Issue 10, 2007, Pages 2547-2550

  Vidarsdottir, Solrun ^a   Smeets, Paul A M ^b   Eichelsheim, Diane L ^a   Van Osch, Matthias J P ^a   Viergever, Max A ^b   Romijn, Johannes A ^a   Van Der Grond, Jeroen ^a   Pijl, Hanno ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; OXYGEN; WATER;

ADULT; ARTICLE; BRAIN NERVE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; FLUID INTAKE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLUCOSE INTAKE; HUMAN; HYPOTHALAMUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OXYGEN BLOOD LEVEL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADMINISTRATION, ORAL; BODY SIZE; DIABETES MELLITUS, TYPE 2; ENERGY INTAKE; ENERGY METABOLISM; GLUCOSE; HUMANS; HYPOTHALAMUS; INSULIN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURONS; REFERENCE VALUES; SIGNAL TRANSDUCTION; SINGLE-BLIND METHOD; TRIGLYCERIDES;

EID: 34948874237     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db07-0193     Document Type: Article

References (20)

1. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW: Central nervous system control of food intake and body weight. Nature 443:289-295, 2006
2. Smeets PA, de Graaf C, Stafleu A, van Osch MJ, van der GJ: Functional MRI of human hypothalamic responses following glucose ingestion. Neuroimage 24:363-368, 2005
3. Schwartz MW, Porte D Jr: Diabetes, obesity, and the brain. Science 307:375-379, 2005
4. Shmuel A, Augath M, Oeltermann A, Logothetis NK: Negative functional MRI response correlates with decreases in neuronal activity in monkey visual area V1. Nat Neurosci 9:569-577, 2006
5. Logothetis NK, Pfeuffer J: On the nature of the BOLD fMRI contrast mechanism. Magn Reson Imaging 22:1517-1531, 2004
6. Matsuda M, Liu Y, Mahankali S, Pu Y, Mahankali A, Wang J, DeFronzo RA, Fox PT, Gao JH: Altered hypothalamic function in response to glucose ingestion in obese humans. Diabetes 48:1801-1806, 1999
7. Cho ZH, Son YD, Kang CK, Han JY, Wong EK, Bai SJ: Pain dynamics observed by functional magnetic resonance imaging: differential regression analysis technique. J Magn Reson Imaging 18:273-283, 2003
8. Liu Y, Gao JH, Liu HL, Fox PT: The temporal response of the brain after eating revealed by functional MRI. Nature 405:1058-1062, 2000
9. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR: A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379:69-72, 1996
10. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR: Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418:650-654, 2002
11. van den Hoek AM, Voshol PJ, Karnekamp BN, Buijs RM, Romijn JA, Havekes LM, Pijl H: Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin. Diabetes 53:2529-2534, 2004
12. van den Hoek AM, Heijboer AC, Corssmit EP, Voshol PJ, Romijn JA, Havekes LM, Pijl H: PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet. Diabetes 53:1949-1952, 2004
13. Badman MK, Flier JS: The gut and energy balance: visceral allies in the obesity wars. Science 307:1909-1914, 2005
14. Levin BE, Kang L, Sanders NM, Dunn-Meynell AA: Role of neuronal glucosensing in the regulation of energy homeostasis. Diabetes 55 (Suppl. 2):S122-S130, 2006
15. Porte D Jr, Baskin DG, Schwartz MW: Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes 54:1264-1276, 2005
16. Smeets PA, de Graaf C, Stafleu A, van Osch MJ, van der GJ: Functional magnetic resonance imaging of human hypothalamic responses to sweet taste and calories. Am J Clin Nutr 82:1011-1016, 2005
17. Nauck MA, Baller B, Meier JJ: Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes. Diabetes 53 (Suppl. 3):S190-S196, 2004
18. Alvarez E, Martinez MD, Roncero I, Chowen JA, Garcia-Cuartero B, Gispert JD, Sanz C, Vazquez P, Maldonado A, de Caceres J, Desco M, Pozo MA, Blazquez E: The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem. J Neurochem 92:798-806, 2005
19. Hamel E: Perivascular nerves and the regulation of cerebrovascular tone. J Appl Physiol 100:1059-1064, 2006
20. Rosengarten B, Aldinger C, Spiller A, Kaps M: Neurovascular coupling remains unaffected during normal aging. J Neuroimaging 13:43-47, 2003